Man Group’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Sell |
26,302
-22,333
| -46% | -$534K | ﹤0.01% | 1542 |
|
|
2025
Q1 | $1.21M | Buy |
+48,635
| New | +$1.21M | ﹤0.01% | 1331 |
|
|
2024
Q4 | – | Sell |
-69,031
| Closed | -$1.04M | – | 1977 |
|
|
2024
Q3 | $1.04M | Sell |
69,031
-21,575
| -24% | -$325K | ﹤0.01% | 1355 |
|
|
2024
Q2 | $2.59M | Buy |
90,606
+37,821
| +72% | +$1.08M | 0.01% | 1148 |
|
|
2024
Q1 | $1.54M | Sell |
52,785
-26,098
| -33% | -$763K | ﹤0.01% | 1287 |
|
|
2023
Q4 | $2.66M | Buy |
+78,883
| New | +$2.66M | 0.01% | 1091 |
|
|
2023
Q3 | – | Sell |
-58,964
| Closed | -$2.36M | – | 1113 |
|
|
2023
Q2 | $2.36M | Buy |
+58,964
| New | +$2.36M | 0.01% | 1121 |
|
|
2023
Q1 | – | Sell |
-96,707
| Closed | -$3.73M | – | 1213 |
|
|
2022
Q4 | $3.73M | Buy |
+96,707
| New | +$3.73M | 0.01% | 934 |
|
|
2022
Q3 | – | Hold |
0
| – | -$836K | – | 2116 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1369 |
|
|
2022
Q1 | – | Sell |
-5,244
| Closed | -$316K | – | 2136 |
|
|
2021
Q4 | $316K | Buy |
+5,244
| New | +$316K | ﹤0.01% | 1632 |
|
|
2021
Q1 | – | Sell |
-75,647
| Closed | -$4.53M | – | 1957 |
|
|
2020
Q4 | $4.53M | Sell |
75,647
-122,990
| -62% | -$7.36M | 0.02% | 858 |
|
|
2020
Q3 | $11.9M | Sell |
198,637
-11,642
| -6% | -$700K | 0.05% | 410 |
|
|
2020
Q2 | $11M | Sell |
210,279
-29,604
| -12% | -$1.55M | 0.06% | 331 |
|
|
2020
Q1 | $8.04M | Buy |
239,883
+156,663
| +188% | +$5.25M | 0.05% | 352 |
|
|
2019
Q4 | $3.77M | Buy |
83,220
+53,774
| +183% | +$2.44M | 0.01% | 1096 |
|
|
2019
Q3 | $1.12M | Buy |
29,446
+11,446
| +64% | +$436K | ﹤0.01% | 1389 |
|
|
2019
Q2 | $783K | Buy |
+18,000
| New | +$783K | ﹤0.01% | 1577 |
|
|
2019
Q1 | – | Sell |
-14,217
| Closed | -$612K | – | 2025 |
|
|
2018
Q4 | $612K | Sell |
14,217
-31,600
| -69% | -$1.36M | ﹤0.01% | 1577 |
|
|
2018
Q3 | $2.25M | Buy |
45,817
+33,018
| +258% | +$1.62M | 0.01% | 1359 |
|
|
2018
Q2 | $410K | Buy |
+12,799
| New | +$410K | ﹤0.01% | 1839 |
|